Huons Co Ltd banner
H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 26 850 KRW 0.94%
Market Cap: ₩321.7B

P/OCF

6.6
Current
4%
Cheaper
vs 3-y average of 6.9

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
6.6
=
Market Cap
₩338.5B
/
Operating Cash Flow
₩47.6B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
6.6
=
Market Cap
₩338.5B
/
Operating Cash Flow
₩47.6B

Valuation Scenarios

Huons Co Ltd is trading below its 3-year average

If P/OCF returns to its 3-Year Average (6.9), the stock would be worth ₩28 067.49 (5% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+133%
Average Upside
51%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 6.6 ₩26 850
0%
3-Year Average 6.9 ₩28 067.49
+5%
5-Year Average 8.5 ₩34 606.77
+29%
Industry Average 15.3 ₩62 605.8
+133%
Country Average 9 ₩36 729.59
+37%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
KR
Huons Co Ltd
KOSDAQ:243070
312.9B KRW 6.6 8.8
US
Eli Lilly and Co
NYSE:LLY
835.2B USD 49.7 40.5
US
Johnson & Johnson
NYSE:JNJ
547.8B USD 22.3 26
CH
Roche Holding AG
SIX:ROG
248.4B CHF 13.7 20.1
UK
AstraZeneca PLC
LSE:AZN
216.4B GBP 19.7 28
CH
Novartis AG
SIX:NOVN
223.1B CHF 14.3 19.5
US
Merck & Co Inc
NYSE:MRK
276.9B USD 16.8 15.2
IE
Endo International PLC
LSE:0Y5F
244.4B USD 907.7 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 9.8 11.4
US
Pfizer Inc
NYSE:PFE
153.5B USD 13.1 19.8
US
Bristol-Myers Squibb Co
NYSE:BMY
118.2B USD 8.3 16.8
P/E Multiple
Earnings Growth PEG
KR
H
Huons Co Ltd
KOSDAQ:243070
Average P/E: 20.6
8.8
16%
0.5
US
Eli Lilly and Co
NYSE:LLY
40.5
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
26
8%
3.3
CH
Roche Holding AG
SIX:ROG
20.1
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
28
25%
1.1
CH
Novartis AG
SIX:NOVN
19.5
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.2
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.8
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.8
16%
1

Market Distribution

In line with most companies in Korea
Percentile
42st
Based on 1 012 companies
42st percentile
6.6
Low
0.2 — 4.2
Typical Range
4.2 — 16.6
High
16.6 —
Distribution Statistics
Korea
Min 0.2
30th Percentile 4.2
Median 9
70th Percentile 16.6
Max 2 215 132.4

Huons Co Ltd
Glance View

Market Cap
321.7B KRW
Industry
Pharmaceuticals

Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.

Intrinsic Value
32 806.51 KRW
Undervaluation 18%
Intrinsic Value
Price ₩26 850
H
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett